KalVista Pharmaceuticals, Inc

(NASDAQ:KALV)

Latest On KalVista Pharmaceuticals, Inc (KALV):

Date/Time Type Description Signal Details
2023-03-09 18:30 ESTNewsKalVista Pharmaceticals GAAP EPS of -$0.75 beats by $0.26N/A
2023-02-14 10:17 ESTNewsKalVista stock rises on regulatory guidance for hereditary angioedema therapyN/A
2023-01-25 18:21 ESTNewsKalVista Pharmaceuticals: The Share Price Rally Requires An Adjustment Of My Investment ThesisN/A
2022-12-27 23:34 ESTNewsKalVista stock rises ~20% on $58M stock, warrants offeringN/A
2022-12-27 08:25 ESTNewsKalVista stock dips on $58M stock, warrants offeringN/A
2022-12-09 20:24 ESTNewsKalVista Pharmaceuticals GAAP EPS of -$0.90 beats by $0.16N/A
2022-12-08 09:31 ESTNewsKalVista Pharmaceticals GAAP EPS of -$0.90 beats by $0.16N/A
2022-10-31 19:59 ESTNewsKalVista's hereditary angioedema drug's orally disintegrating version shows promise in trialN/A
2022-10-17 16:38 ESTNewsKalVista Pharmaceuticals appoints Brian J.G. Pereira as Board ChairmanN/A
2022-10-14 19:01 ESTNewsKalVista: Another Setback But The Key Value Driver Is Still In PlaceN/A
2022-10-04 18:00 ESTNewsKalVista stock slumps 37% as KVD824 trial for hereditary angioedema ended over liver safety concernsN/A
2022-09-08 13:08 ESTNewsKalVista Pharmaceticals GAAP EPS of -$0.94N/A
2022-08-23 05:02 ESTNewsKalVista reaches five-month high as rival tumbles on hereditary angioedemaN/A
2022-07-07 14:49 ESTNewsKalVista Pharmaceticals GAAP EPS of -$0.98 beats by $0.11N/A
2022-03-10 17:54 ESTNewsKalVista Pharmaceticals GAAP EPS of -$0.92 in-lineN/A
2022-03-07 21:49 ESTNewsKalVista begins phase 3 trial of oral drug KVD900 to treat hereditary angioedema attacksN/A
2022-01-04 14:36 ESTNewsKalVista Pharmaceuticals grants inducement options to four new employeesN/A
2021-12-14 16:42 ESTNewsWarning: KALV is at high risk of performing badlyN/A
2021-12-03 16:14 ESTNewsKalVista Pharmaceuticals reports inducement grants to 6 new employeesN/A
2021-11-24 00:36 ESTNewsKalvista Pharmaceuticals (KALV) Investor Presentation - SlideshowN/A
2021-11-10 10:35 ESTNewsKalVista to begin dosing in late-stage hereditary angioedema study early next yearN/A
2021-09-27 20:18 ESTNewsWarning: KALV has been downgraded to Very BearishN/A
2021-09-23 06:04 ESTNewsWarning: KALV has been downgraded to Very Bearish.N/A
2021-09-21 22:18 ESTNewsKalVista announces lifting of clinical hold placed on hereditary angioedema studyN/A
2021-09-09 06:47 ESTNewsKalVista Pharmaceticals EPS beats by $0.06N/A
2021-07-21 13:37 ESTNewsKalVista Pharmaceuticals files for $300M mixed shelf offeringN/A
2021-07-21 13:29 ESTNewsKalVista Pharma's oral KVD900 shows rapid improvement in HAE attacks in mid-stage studyN/A
2021-07-21 13:15 ESTNewsKalVista and BioCryst fall after Intellia shows promise in gene editingN/A
2021-07-21 13:14 ESTNewsKalVista favored at Cantor despite emerging threat from IntelliaN/A
2021-07-21 13:13 ESTNewsKalVista, BioCryst's rough week continues as shares down againN/A
2021-07-21 13:08 ESTNewsKalVista Pharma's KVD900 slows progression, accelerates resolution of attacks in HAE patientsN/A
2021-07-21 13:07 ESTNewsKalVista Pharmaceticals EPS misses by $0.10N/A
2021-05-04 00:57 ESTNewsKalVista Pharmaceuticals names new medical chiefN/A
2021-04-20 07:11 ESTNewsFDA puts clinical hold on KalVista Pharma's mid-stage KVD824 trialN/A
2021-03-16 21:12 ESTAnalyst RatingThe Analyst Target Price has decreased from $55.71 to $55.43.Neutral
2021-03-12 07:58 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 04:01 ESTEarnings EstimateAn EPS average of -$0.69 is estimated for the quarter ending on July 31, 2021.Sell
2021-03-11 09:15 ESTNewsKalVista Pharmaceticals EPS beats by $0.04N/A
2021-02-18 04:08 ESTAnalyst RatingThe Analyst Target Price has increased from $46.43 to $55.71.Buy
2021-02-17 11:44 ESTAnalyst RatingThe Analyst Target Price has increased from $42.43 to $46.43.Buy
2021-02-17 05:19 ESTNewsKalVista Pharmaceuticals closes $222.5M capital raiseN/A
2021-02-11 11:51 ESTAnalyst RatingThe Analyst Target Price has increased from $39.86 to $42.43.Buy
2021-02-11 08:37 ESTNewsKalVista Pharma secures $193.5M via equity offering; shares up 6%N/A
2021-02-10 13:45 ESTNewsTLRY, GLUU, ABEO and TYME among premarket gainersN/A
2021-02-10 13:45 ESTNewsKalVista stock catapults on positive mid-stage KVD900 trial dataN/A
2021-02-10 13:44 ESTNewsKalVista announces proposed 4.5M public offeringN/A
2021-02-10 13:44 ESTNewsKalVista extends gains as Jefferies raise price target on positive angioedema dataN/A
2021-02-10 11:52 ESTAnalyst RatingThe Analyst Target Price has increased from $30.86 to $39.86.Neutral
2021-01-27 12:02 ESTAnalyst RatingThe Analyst Target Price has increased from $29.86 to $30.86.Buy
2021-01-06 15:58 ESTFinancialsCompany financials have been released.Neutral

About KalVista Pharmaceuticals, Inc (KALV):

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which is in Phase II clinical trial for treating HAE attacks; and KVD824, an oral plasma kallikrein inhibitor that completed a Phase I clinical trial for treating DME or HAE. The company is headquartered in Cambridge, Massachusetts.

See Advanced Chart

General

  • Name KalVista Pharmaceuticals, Inc
  • Symbol KALV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 56
  • Last Split Factor1:14
  • Last Split Date2016-11-22
  • Fiscal Year EndApril
  • IPO Date2015-04-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.kalvista.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 152.05
  • Price/Book (Most Recent Quarter) 13.49
  • Enterprise Value Revenue 137.27
View More

Financials

  • Most Recent Quarter 2021-01-31
  • Current Year EPS Estimate -$2.27
  • Next Year EPS Estimate -$2.86
  • Operating Margin -1277%
  • Return on Assets -36%
  • Return on Equity -51%
  • Revenue 3.82 million
  • Earnings Per Share -$1.38
  • Revenue Per Share $0.21
  • Gross Profit -27504000
  • Quarterly Earnings Growth 30.7%
View More

Highlights

  • Market Capitalization 868.78 million
  • EBITDA -31926000
  • PE Ratio -15.23
  • Analyst Target Price $55.43
  • Book Value Per Share $3.25
View More

Share Statistics

  • Shares Outstanding 24.12 million
  • Shares Float 21.27 million
  • % Held by Insiders 906%
  • % Held by Institutions 96.23%
  • Shares Short 782353
  • Shares Short Prior Month 641079
  • Short Ratio 0.34
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 2.17
  • 52 Week High $43.08
  • 52 Week Low $5.63
  • 50 Day Moving Average 29.76
  • 200 Day Moving Average 19.69
View More

Dividends

  • Dividend Date 2016-11-22
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

KalVista Pharmaceuticals, Inc (KALV) Dividend Calendar:

KALV's last dividend payment was made to shareholders on November 22, 2016.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

KalVista Pharmaceuticals, Inc (KALV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2021-01-312021-03-11$N/A-$0.56-$0.595.08%
2020-10-312020-12-10$N/A-$0.58-$0.6612.12%
2020-07-312020-09-14$N/A-$0.61-$0.55-11.93%
2020-04-302020-06-29$3.82 million-$0.37-$0.6139.34%
2020-01-312020-03-10$1.58 million-$0.52-$0.520%
2019-10-312019-12-03$N/A-$0.33-$0.5438.51%
2019-07-312019-09-09$3.37 million-$0.42-$0.5928.21%
2019-04-302019-07-15$2.93 million-$0.49-$0.35-39.01%
2019-01-312019-03-14$3.89 million-$0.23-$0.4650.36%
2018-10-312018-12-14$5.59 million-$0.22-$0.4247.93%
2018-07-312018-09-14$3.72 million-$0.47-$0.33-42.42%
2018-04-302018-07-30$4.84 million-$0.04-$0.3588.57%
2018-01-312018-03-16$2.33 million-$0.49-$0.13-276.92%
2017-10-312017-12-14$1.13 million-$0.50-$0.45-11.11%
2017-07-312017-09-14$96000-$0.51-$0.5913.56%
2017-04-302017-07-27$1.24 million-$0.43
2017-01-312017-03-16$248000-$1.03
2016-07-312016-08-12$945000-$3.92-$3.50-12%
2016-04-302016-05-12$2.13 million-$3.50-$2.59-35.14%
2016-01-312016-03-30$7000-$3.21-$3.364.46%
2015-10-312015-11-11$8000-$2.66-$3.6026.11%
2015-07-312015-08-11$7000-$5.18-$2.89-79.24%
2015-04-302015-05-15$7000-$103.32-$2.33-4334.33%

KalVista Pharmaceuticals, Inc (KALV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

KalVista Pharmaceuticals, Inc (KALV) Chart:

KalVista Pharmaceuticals, Inc (KALV) News:

Below you will find a list of latest news for KalVista Pharmaceuticals, Inc (KALV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

KalVista Pharmaceuticals, Inc (KALV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-162.50CALL0 01464.41TRUE00
2025-05-1650CALL0 0354.02TRUE00
2025-05-167.50CALL0 0393.77TRUE00
2025-05-16100CALL0 0287.5TRUE00
2025-05-1612.51.2CALL1 2479.08TRUE1.20
2025-05-16150CALL0 061.26FALSE00
2025-05-1617.50CALL0 0302.64FALSE00
2025-05-16200CALL0 0155.04FALSE00
2025-05-1622.50CALL0 0180.83FALSE00
2025-05-162.50PUT0 0558.62FALSE00
2025-05-1650PUT0 0332.44FALSE00
2025-05-167.50PUT0 0510.12FALSE00
2025-05-16100.8PUT0 297.88FALSE00
2025-05-1612.50PUT0 0137.31FALSE00
2025-05-16150PUT0 036.01TRUE00
2025-05-1617.50PUT0 0148.91TRUE00
2025-05-16200PUT0 0132.9TRUE00
2025-05-1622.50PUT0 0157.43TRUE00
2025-06-202.50CALL0 0761.04TRUE00
2025-06-2054.1CALL0 1398.34TRUE00
2025-06-207.55.4CALL0 24136.67TRUE00
2025-06-20103.2CALL0 15190.89TRUE00
2025-06-2012.52CALL20 117288.64TRUE20
2025-06-20151.06CALL0 94195.75FALSE00
2025-06-2017.50.25CALL0 4182.9FALSE00
2025-06-20200.1CALL0 1182.87FALSE00
2025-06-2022.50.15CALL0 3135.53FALSE00
2025-06-202.50PUT0 0347.88FALSE00
2025-06-2050.5PUT0 1487.65FALSE00
2025-06-207.50.5PUT0 35137.17FALSE00
2025-06-20100.8PUT0 3227108.34FALSE00
2025-06-2012.51.82PUT0 3196.75FALSE00
2025-06-20154.6PUT0 177.49TRUE00
2025-06-2017.55.85PUT0 071.71TRUE00
2025-06-20200PUT0 067.83TRUE00
2025-06-2022.50PUT0 097.33TRUE00
2025-09-192.57.1CALL0 14123.54TRUE00
2025-09-1957.3CALL0 0245.34TRUE00
2025-09-197.55.4CALL0 483.96TRUE00
2025-09-19104CALL0 3179.37TRUE00
2025-09-1912.52.5CALL0 13984.43TRUE00
2025-09-19151.7CALL1 50672.62FALSE0.10.06
2025-09-1917.51.1CALL1 2572.67FALSE1.10
2025-09-19200.7CALL1 072.28FALSE0.70
2025-09-1922.50CALL0 085.16FALSE00
2025-09-192.50PUT0 0299.73FALSE00
2025-09-1950PUT0 0175.59FALSE00
2025-09-197.50PUT0 0114.39FALSE00
2025-09-19101.65PUT0 1776.08FALSE00
2025-09-1912.52.55PUT0 4878.87FALSE00
2025-09-19150PUT0 064.25TRUE00
2025-09-1917.56.19PUT0 071.63TRUE00
2025-09-19200PUT0 079.1TRUE00
2025-09-1922.50PUT0 070.13TRUE00
2025-12-192.50CALL0 0414.66TRUE00
2025-12-1950CALL0 090.26TRUE00
2025-12-197.50CALL0 095.53TRUE00
2025-12-19104.6CALL4 276.81TRUE00
2025-12-1912.50CALL0 070.89TRUE00
2025-12-19150CALL0 060.28FALSE00
2025-12-1917.50CALL0 058.88FALSE00
2025-12-19200CALL0 066.14FALSE00
2025-12-1922.50CALL0 058.87FALSE00
2025-12-192.50PUT0 0171.91FALSE00
2025-12-1950PUT0 0142.57FALSE00
2025-12-197.50PUT0 095.56FALSE00
2025-12-19100PUT0 077.97FALSE00
2025-12-1912.50PUT0 070.57FALSE00
2025-12-19150PUT0 088.22TRUE00
2025-12-1917.50PUT0 082.65TRUE00
2025-12-19200PUT0 072.25TRUE00
2025-12-1922.50PUT0 091.81TRUE00

Latest KALV Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$8.17
Jun 13, 2022 7:59 PM EST2$8.17
Jun 13, 2022 7:59 PM EST100$8.18
Jun 13, 2022 7:59 PM EST5$8.18
Jun 13, 2022 7:59 PM EST2$8.18

KalVista Pharmaceuticals, Inc (KALV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020031523/0001564590-20-031523-index.htm
2018-12-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1348911/000000000018038823/0000000000-18-038823-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000031506620001058/0000315066-20-001058-index.htm
2020-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000031506620001437/0000315066-20-001437-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm
2019-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000110465920021718/0001104659-20-021718-index.htm
2019-04-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1348911/000114420419019693/0001144204-19-019693-index.htm
2019-04-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1348911/000114420419020958/0001144204-19-020958-index.htm
2018-12-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1348911/000119312518350025/0001193125-18-350025-index.htm
2018-12-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1348911/000119312518354546/0001193125-18-354546-index.htm
2019-02-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1348911/000119312519050840/0001193125-19-050840-index.htm
2019-03-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1348911/000119312519080883/0001193125-19-080883-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1348911/000119312519092927/0001193125-19-092927-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000119312519092945/0001193125-19-092945-index.htm
2019-04-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1348911/000119312519096580/0001193125-19-096580-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000119312519261630/0001193125-19-261630-index.htm
2020-03-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000119312520082504/0001193125-20-082504-index.htm
2020-08-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1348911/000119312520229923/0001193125-20-229923-index.htm
2019-04-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000119380519000378/0001193805-19-000378-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000119380520000199/0001193805-20-000199-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053393/0001209191-20-053393-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053394/0001209191-20-053394-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053395/0001209191-20-053395-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053396/0001209191-20-053396-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053397/0001209191-20-053397-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053398/0001209191-20-053398-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120053399/0001209191-20-053399-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055362/0001209191-20-055362-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055363/0001209191-20-055363-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055365/0001209191-20-055365-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120056468/0001209191-20-056468-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000120919120056919/0001209191-20-056919-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000121390020003600/0001213900-20-003600-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459018023592/0001564590-18-023592-index.htm
2018-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459018023967/0001564590-18-023967-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459018030918/0001564590-18-030918-index.htm
2018-12-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459018030939/0001564590-18-030939-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019001698/0001564590-19-001698-index.htm
2019-03-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459019007827/0001564590-19-007827-index.htm
2019-03-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1348911/000156459019007847/0001564590-19-007847-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019007850/0001564590-19-007850-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019012737/0001564590-19-012737-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019024241/0001564590-19-024241-index.htm
2019-07-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1348911/000156459019025007/0001564590-19-025007-index.htm
2019-07-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1348911/000156459019025009/0001564590-19-025009-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019025066/0001564590-19-025066-index.htm
2019-08-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1348911/000156459019032858/0001564590-19-032858-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019034361/0001564590-19-034361-index.htm
2019-09-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459019034364/0001564590-19-034364-index.htm
2019-12-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459019045155/0001564590-19-045155-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459019045159/0001564590-19-045159-index.htm
2020-03-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459020009752/0001564590-20-009752-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020009764/0001564590-20-009764-index.htm
2020-03-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1348911/000156459020009778/0001564590-20-009778-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020029018/0001564590-20-029018-index.htm
2020-07-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1348911/000156459020031501/0001564590-20-031501-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020031523/0001564590-20-031523-index.htm
2020-09-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1348911/000156459020043418/0001564590-20-043418-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020043423/0001564590-20-043423-index.htm
2020-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1348911/000156459020045741/0001564590-20-045741-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918002982/0001567619-18-002982-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918002983/0001567619-18-002983-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918002984/0001567619-18-002984-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918002985/0001567619-18-002985-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918003781/0001567619-18-003781-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918003782/0001567619-18-003782-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918003783/0001567619-18-003783-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761918003784/0001567619-18-003784-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm
2019-01-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919001608/0001567619-19-001608-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm
2019-02-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919002401/0001567619-19-002401-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919002402/0001567619-19-002402-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919007013/0001567619-19-007013-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm
2019-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm
2019-04-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919009058/0001567619-19-009058-index.htm
2019-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919009059/0001567619-19-009059-index.htm
2019-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm
2019-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919011569/0001567619-19-011569-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919011575/0001567619-19-011575-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919011577/0001567619-19-011577-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919011579/0001567619-19-011579-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919011583/0001567619-19-011583-index.htm
2019-06-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919012846/0001567619-19-012846-index.htm
2019-06-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919014121/0001567619-19-014121-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919014122/0001567619-19-014122-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919014946/0001567619-19-014946-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919019233/0001567619-19-019233-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919019234/0001567619-19-019234-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919019235/0001567619-19-019235-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919023611/0001567619-19-023611-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761920002452/0001567619-20-002452-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761920002453/0001567619-20-002453-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000156761920002454/0001567619-20-002454-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000158064219000781/0001580642-19-000781-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1348911/000158064220000514/0001580642-20-000514-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1348911/000160226419000001/0001602264-19-000001-index.htm
2018-12-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1348911/999999999518003215/9999999995-18-003215-index.htm

KalVista Pharmaceuticals, Inc (KALV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of KalVista Pharmaceuticals, Inc (KALV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 906%
Institutional Ownership: 9623%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-05Andreas MaetzelSenior Vice President MedicalSell5,000.0030.00150,011.000.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm
2019-09-27DANIEL B SOLANDDirectorBuy7,962.0011.8794,497.7910,000.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm
2019-04-17Edward P. FeenerChief Scientific OfficerSell916.0025.3923,260.17100,034.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm
2019-04-17Edward P. FeenerChief Scientific OfficerSell3,084.0024.7876,406.10100,950.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm
2019-07-29Albert ChaDirectorBuy24,730.0017.13423,691.671,022,493.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm
2019-01-16Edward P. FeenerChief Scientific OfficerSell2,300.0019.8145,572.43104,034.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm
2019-07-17Albert ChaDirectorBuy220.0016.933,724.01104,551.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm
2019-01-16Edward P. FeenerChief Scientific OfficerSell1,700.0019.2032,637.45106,334.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm
2020-10-30Albert ChaDirectorBuy68,255.0017.171,171,808.671,090,748.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm
2018-09-18Edward P. FeenerChief Scientific OfficerBuy12,500.00110,534.00https://www.sec.gov/Archives/edgar/data/1348911/000156761918002984/0001567619-18-002984-index.htm
2020-10-30Albert ChaDirectorBuy47,431.0017.34822,259.071,138,179.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm
2019-07-19Albert ChaDirectorBuy10,320.0017.68182,453.47114,871.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm
2019-07-26Albert ChaDirectorBuy4,558.0016.8376,717.98119,429.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm
2019-07-29Albert ChaDirectorBuy5,137.0017.1388,010.68124,566.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm
2019-03-18Venrock Healthcare Capital Partners II, L.P.10% Share HolderSell500,000.0028.7514,375,000.001,544,112.00https://www.sec.gov/Archives/edgar/data/1348911/000160226419000001/0001602264-19-000001-index.htm
2019-04-10SVLSF IV, LLC10% Share HolderSell13,157.0029.40386,752.651,672,105.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-09SVLSF IV, LLC10% Share HolderSell13,292.0028.53379,227.411,685,262.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-08SVLSF IV, LLC10% Share HolderSell22,171.0029.49653,864.911,698,554.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-02SVLSF IV, LLC10% Share HolderSell8,888.0028.76255,652.651,720,725.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-04-01SVLSF IV, LLC10% Share HolderSell51,373.0027.661,420,884.711,729,613.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-03-29SVLSF IV, LLC10% Share HolderSell34,133.0028.40969,240.671,780,986.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-03-28SVLSF IV, LLC10% Share HolderSell35,653.0027.80991,189.051,815,119.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-27SVLSF IV, LLC10% Share HolderSell56,318.0029.061,636,556.031,850,772.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-26SVLSF IV, LLC10% Share HolderSell29,262.0029.70869,008.251,907,090.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-18SVLSF IV, LLC10% Share HolderSell255,224.0026.706,814,480.801,936,352.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm
2020-10-21Thomas Andrew CrockettCEOSell3,693.0019.0170,193.59195,420.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2020-10-21Thomas Andrew CrockettCEOSell13,052.0018.51241,640.81199,113.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2019-09-26DANIEL B SOLANDDirectorBuy2,038.0011.9024,252.202,038.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm
2020-10-21Thomas Andrew CrockettCEOSell5,800.0017.48101,412.42212,165.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2020-10-20Thomas Andrew CrockettCEOSell4,776.0018.0185,991.88217,965.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2019-03-05SVLSF IV, LLC10% Share HolderSell31,439.0023.04724,244.522,191,576.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm
2019-03-04SVLSF IV, LLC10% Share HolderSell42,181.0022.91966,240.172,223,015.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm
2020-10-20Thomas Andrew CrockettCEOSell11,218.0017.27193,786.46222,741.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm
2019-02-21SVLSF IV, LLC10% Share HolderSell167,779.0020.603,456,247.402,265,196.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2020-10-16Thomas Andrew CrockettCEOSell1,261.0017.0121,444.06236,959.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055362/0001209191-20-055362-index.htm
2020-02-05Thomas Andrew CrockettCEOSell200.0017.053,410.00238,220.00https://www.sec.gov/Archives/edgar/data/1348911/000156761920002452/0001567619-20-002452-index.htm
2019-12-20Thomas Andrew CrockettCEOSell2,300.0017.0239,150.37238,420.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023611/0001567619-19-023611-index.htm
2019-12-16Thomas Andrew CrockettCEOSell5,400.0017.0692,115.90240,720.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm
2019-02-20SVLSF IV, LLC10% Share HolderSell22,594.0020.02452,239.242,432,975.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2019-02-19SVLSF IV, LLC10% Share HolderSell17,912.0020.73371,365.912,455,569.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2019-12-13Thomas Andrew CrockettCEOSell2,200.0017.0637,536.40246,120.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm
2019-01-07SVLSF IV, LLC10% Share HolderSell2,527.0020.4151,581.122,473,481.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm
2019-01-03SVLSF IV, LLC10% Share HolderSell1,653.0020.0133,081.492,476,008.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm
2019-01-02SVLSF IV, LLC10% Share HolderSell194.0020.003,880.002,477,661.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2018-12-31SVLSF IV, LLC10% Share HolderSell24,716.0020.00494,418.862,477,855.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2019-12-12Thomas Andrew CrockettCEOSell100.0017.001,700.00248,320.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm
2019-07-15Thomas Andrew CrockettCEOSell10,000.0017.04170,407.00248,510.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919014946/0001567619-19-014946-index.htm
2018-12-28SVLSF IV, LLC10% Share HolderSell3,631.0020.0372,718.042,502,571.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2018-12-19SVLSF IV, LLC10% Share HolderSell2,077.0020.0241,577.392,506,202.00https://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm
2019-04-15Thomas Andrew CrockettCEOSell300.0025.927,776.99258,510.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm
2019-04-15Thomas Andrew CrockettCEOSell9,700.0024.76240,180.73258,810.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm
2019-03-14Thomas Andrew CrockettCEOSell3,000.0030.1690,483.90268,510.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919007013/0001567619-19-007013-index.htm
2019-01-14Thomas Andrew CrockettCEOSell901.0019.8617,895.93271,510.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm
2019-01-14Thomas Andrew CrockettCEOSell9,099.0019.28175,432.36272,411.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm
2018-09-18Benjamin L PalleikoCFO and SecretaryBuy32,500.0032,500.00https://www.sec.gov/Archives/edgar/data/1348911/000156761918002982/0001567619-18-002982-index.htm
2019-04-18Benjamin L PalleikoCBO, CFO and SecretarySell1,073.0025.5127,373.4132,500.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm
2019-04-22Benjamin L PalleikoCBO, CFO and SecretarySell2,000.0025.8051,603.0032,500.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm
2019-04-18Benjamin L PalleikoCBO, CFO and SecretaryBuy1,073.006.747,232.0233,573.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm
2019-04-22Benjamin L PalleikoCBO, CFO and SecretaryBuy2,000.008.3916,780.0034,500.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm
2019-04-10SVLSF IV, LLC10% Share HolderSell374.0029.4010,993.8047,471.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-09SVLSF IV, LLC10% Share HolderSell377.0028.5310,756.0047,845.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-08SVLSF IV, LLC10% Share HolderSell629.0029.4918,550.4148,222.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm
2019-04-02SVLSF IV, LLC10% Share HolderSell253.0028.767,277.2448,851.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-04-01SVLSF IV, LLC10% Share HolderSell1,458.0027.6640,325.6649,104.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-04-05Andreas MaetzelSenior Vice President MedicalBuy5,000.007.9139,550.005,000.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm
2019-03-29SVLSF IV, LLC10% Share HolderSell969.0028.4027,515.7250,562.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm
2019-03-28SVLSF IV, LLC10% Share HolderSell1,012.0027.8028,134.6151,531.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-27SVLSF IV, LLC10% Share HolderSell1,599.0029.0646,465.6652,543.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-26SVLSF IV, LLC10% Share HolderSell831.0029.7024,678.6254,142.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm
2019-03-18SVLSF IV, LLC10% Share HolderSell7,246.0026.70193,468.2054,973.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm
2019-03-05SVLSF IV, LLC10% Share HolderSell893.0023.0420,571.5962,219.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm
2020-10-29Christopher YeaChief Development OfficerSell5,000.0017.4887,394.0062,969.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120056468/0001209191-20-056468-index.htm
2019-03-04SVLSF IV, LLC10% Share HolderSell1,197.0022.9127,419.6863,112.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm
2019-02-21SVLSF IV, LLC10% Share HolderSell4,764.0020.6098,138.4064,309.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2020-10-21Christopher YeaChief Development OfficerSell2,544.0019.0248,388.6667,969.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm
2019-02-20SVLSF IV, LLC10% Share HolderSell641.0020.0212,830.1969,073.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2019-02-19SVLSF IV, LLC10% Share HolderSell508.0020.7310,532.2669,714.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm
2019-01-07SVLSF IV, LLC10% Share HolderSell72.0020.411,469.6670,222.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm
2019-01-03SVLSF IV, LLC10% Share HolderSell47.0020.01940.6170,294.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm
2019-01-02SVLSF IV, LLC10% Share HolderSell6.0020.00120.0070,341.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2018-12-31SVLSF IV, LLC10% Share HolderSell702.0020.0014,042.8170,347.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2020-10-21Christopher YeaChief Development OfficerSell3,500.0017.6861,892.9570,513.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm
2018-12-28SVLSF IV, LLC10% Share HolderSell103.0020.032,062.7871,049.00https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm
2018-12-19SVLSF IV, LLC10% Share HolderSell59.0020.021,181.0671,152.00https://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm
2020-11-02Edward P. FeenerChief Scientific OfficerSell6,000.0017.14102,811.8072,734.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120056919/0001209191-20-056919-index.htm
2020-10-20Christopher YeaChief Development OfficerSell2,302.0018.0141,466.6274,013.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm
2020-10-20Christopher YeaChief Development OfficerSell5,640.0017.2797,419.1676,315.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm
2020-10-21Edward P. FeenerChief Scientific OfficerSell5,407.0018.75101,374.2278,734.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm
2020-10-16Christopher YeaChief Development OfficerSell914.0017.0015,539.2881,955.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055365/0001209191-20-055365-index.htm
2020-02-05Christopher YeaChief Development OfficerSell100.0017.101,710.0082,869.00https://www.sec.gov/Archives/edgar/data/1348911/000156761920002454/0001567619-20-002454-index.htm
2019-01-22Christopher YeaChief Development OfficerSell1,302.0017.0022,138.9582,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm
2019-01-23Christopher YeaChief Development OfficerSell600.0017.0110,204.9882,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm
2019-01-25Christopher YeaChief Development OfficerSell5,453.0017.0693,015.0982,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm
2019-04-22Christopher YeaChief Development OfficerSell1,000.0026.7926,786.0082,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm
2019-07-22Christopher YeaChief Development OfficerSell7,355.0018.35134,929.6882,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm
2019-12-12Christopher YeaChief Development OfficerSell199.0017.003,383.0082,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-12-13Christopher YeaChief Development OfficerSell1,500.0017.0525,567.9582,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-12-16Christopher YeaChief Development OfficerSell3,010.0017.0551,318.3982,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-12-20Christopher YeaChief Development OfficerSell2,646.0017.0245,025.1382,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm
2019-12-12Christopher YeaChief Development OfficerBuy199.000.000.8683,168.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-01-23Christopher YeaChief Development OfficerBuy600.000.002.5883,569.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm
2019-04-22Christopher YeaChief Development OfficerSell6,355.0025.92164,743.8483,969.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm
2020-10-21Edward P. FeenerChief Scientific OfficerSell3,600.0017.6563,554.0484,141.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm
2019-01-22Christopher YeaChief Development OfficerBuy1,302.000.005.6084,271.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm
2019-12-13Christopher YeaChief Development OfficerBuy1,500.000.006.4584,469.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2019-12-20Christopher YeaChief Development OfficerBuy2,646.000.0011.3885,615.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm
2019-12-16Christopher YeaChief Development OfficerBuy3,010.000.0012.9485,979.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm
2020-10-20Edward P. FeenerChief Scientific OfficerSell2,300.0018.0041,406.9087,741.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm
2019-01-25Christopher YeaChief Development OfficerBuy5,453.000.0023.4588,422.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm
2020-10-20Edward P. FeenerChief Scientific OfficerSell5,600.0017.2696,683.4490,041.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm
2019-04-22Christopher YeaChief Development OfficerBuy7,355.000.0031.6390,324.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm
2019-07-22Christopher YeaChief Development OfficerBuy7,355.000.0031.6390,324.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm
2019-07-17Albert ChaDirectorBuy1,060.0016.9717,990.96926,141.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm
2020-10-16Edward P. FeenerChief Scientific OfficerSell993.0017.0016,881.0095,641.00https://www.sec.gov/Archives/edgar/data/1348911/000120919120055363/0001209191-20-055363-index.htm
2020-02-05Edward P. FeenerChief Scientific OfficerSell100.0017.111,711.0096,634.00https://www.sec.gov/Archives/edgar/data/1348911/000156761920002453/0001567619-20-002453-index.htm
2019-07-23Edward P. FeenerChief Scientific OfficerSell1,900.0018.6535,438.9996,734.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm
2019-07-19Albert ChaDirectorBuy49,680.0017.84886,127.26975,821.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm
2019-07-22Edward P. FeenerChief Scientific OfficerSell1,400.0018.5726,004.0298,634.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm
2019-07-26Albert ChaDirectorBuy21,942.0016.83369,316.77997,763.00https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm